Clinical Trials Browser

INDUSTRY × Has results × lanreotide × Clear all

NCT00353496 2025-03-05

CLARINET

Phase 3 Completed

264 enrolled 17 charts

Endocrine Tumors

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT00842348 2022-10-12

NET729

Phase 3 Completed

89 enrolled 9 charts

Neuroendocrine Tumors

NCT02683941 2022-07-06

SPINET

Phase 3 Terminated

77 enrolled 20 charts

Neuroendocrine Tumors in Lung

NCT02698410 2020-10-01

ATLANT

Phase 2 Completed

40 enrolled 17 charts

Neuroendocrine Tumors

NCT00681187 2019-11-22

SAPHE

Phase 4 Completed

26 enrolled 18 charts

Neuroendocrine Tumour With Carcinoid Symptoms

NCT01313273 2019-11-22

POSEIDON

Phase 3 Terminated

3 enrolled 4 charts

Prostatic Neoplasms

NCT02075606 2019-06-07

CALM-NET

Phase 4 Completed

50 enrolled 12 charts

Neuroendocrine Tumors